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Abstract
Background: Cancers of the male urethra constitute less than 1% of all malignant urological
tumours, and the occurrence of sarcomas in the urethra is even less frequent. To our knowledge,
only one case has been previously described in the English literature.
Case presentation: We report the clinical features, histology, imaging and treatment of urethral
leiomyosarcoma in a male patient.
Conclusion: The occurrence of sarcoma in the urethra is most unusual, and its appearance as a
primary growth in the male urethra is not recorded in the English literature. In conclusion, this case
highlights a rare type of primary male urethral malignancy that features a poor prognosis.
Introduction
Primary sarcoma of the urethra in the male patient is
extremely rare. Malignant neoplasms of the urethra are
typically squamous cell carcinoma. Leiomyosarcoma is a
very rare neoplasm of the urinary system with less than 20
cases being reported in the literature up to date.
We report below the case of a male patient with ureteral
leiomyosarcoma.
Case presentation
A 65-year-old Moroccan male patient had undergone a
perineal urethrostomy to treat an extended distal urethral
stricture. After one year, he presented with 3-month his-
tory of dysuria, pollakiuria and urethral bleeding. About
six weeks previous to examination, slight terminal hema-
turia was noticed. His weight was stable and he appeared
well nourished. Physical examination of the genitals
revealed a firm and non-fluctuant mass embracing the
perineum, the proximal part of the penis and the upper
part of the scrotum (Figure 1). The prostate was small and
showed no evidence of nodulation. A magnetic resonance
imaging test performed on the patient revealed a 6 cm size
heterogeneous mass arising from the bulbomembranous
urethra and invading the proximal part of the cavernous
and spongious bodies (Figure 2). After injection of con-
trast gadolinium, the mass was greatly enhanced, with a
clear portion in the nearby tissues (Figure 3). A biopsy of
the mass was performed, and pathological examination
identified characteristics of leiomyosarcoma. Chest roent-
genogram, bone scan, liver-spleen scan, and computed
tomographic scan of the pelvis were negative for meta-
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static disease. The patient was surgically treated by pelvic
exenteration. Pathological examination showed that the
cancer was composed of fascicles of interlacing, moder-
ately large, spindle-shaped cells, with abundant eosi-
nophilic cytoplasm. Immunohistochemistry showed
strong staining for smooth muscle actin (SMA) (Figure 4
and Figure 5). The cutting margins were positive. The
patient underwent therefore radiotherapy and two cycles
of adjuvant chemotherapy consisting of mesna, doxoru-
bicin, ifosfamide and dacarbazine (MAID regimen). How-
ever, he developed a local recurrence 4 months after
surgery, and the recurrent tumor quickly extended to the
pelvic wall. Then, the tumor metastasized to the lungs.
The patient died of the disease 7 months after surgery.
Discussion
Leiomyosarcoma is a rare soft-tissue tumor that accounts
for 10-20% of soft-tissue sarcoma. It is generally seen in
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middle-aged patients, and affects women more frequently
than men [1]. Its usual locations, in order of decreasing
frequency are: retroperitoneal, intra-abdominal, cutane-
ous and subcutaneous. Leiomyosarcoma is a highly
malignant tumor with an extremely poor prognosis. The
5-year overall survival rate in patients with soft-tissue sar-
coma of all stages remains poor, at only 50-60%, and 5-
year disease-free survival is rare. To our knowledge, only 1
case of urethral leiomyosarcoma has been previously
reported. Wide local excision is considered to be the treat-
ment of choice with radiation and chemotherapy being
offered to patients with positive margins or nodes, or
those with bulky disease [2,3]. If anatomically feasible,
radiotherapy can be considered for larger tumors and/or
positive margins. Adjuvant chemotherapy has not been
proven to be effective and remains investigational.
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